How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey

Where someone lives can profoundly influence their multiple sclerosis journey.

While advances in diagnosis and treatment have transformed MS care in many parts of the world, millions of people still face significant barriers to diagnosis, specialist care and life-changing therapies.

In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Dr. Fiifi Duodu and Prof. Alfredo Damasceno about the realities of managing MS patients in diverse healthcare settings and what can be done to improve equity worldwide.

Together, they discuss:

🔹 Why MS diagnosis can take years in some regions, and how the revised 2024 McDonald Criteria are influencing earlier MS diagnosis

🔹 The impact of limited access to neurologists and MRI

🔹 Barriers to disease-modifying therapies and anti-CD20 treatments

🔹 The role of regional initiatives such as AFRICTRIMS and BCTRIMS

🔹 Why greater diversity in MS clinical trials matters

This episode highlights both the challenges and the remarkable progress being made to improve MS care across the globe.

------------------------

This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(81)

How Technology Is Transforming Multiple Sclerosis Care

Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed. In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of John...

12 Aug 31min

Should High-Risk Populations Be Screened for Multiple Sclerosis?

Could multiple sclerosis one day be detected before symptoms appear? And if so, should we be actively screening people who are at higher risk? In this episode of the ECTRIMS–MS Journal collaboration ...

30 Jul 32min

MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis

Welcome to MS Research Briefs, a new ECTRIMS podcast series delivering an expert guided tour of important new studies in multiple sclerosis research. In each episode, leading MS experts will take a sm...

2 Jul 23min

Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation

Vitamin D and multiple sclerosis have been linked for decades, but how strong is the evidence – and what does it mean for clinical practice? In this episode of the ECTRIMS Podcast, host Brett Drummond...

18 Jun 31min

Can the revised 2024 McDonald Diagnostic criteria solve the misdiagnosis problem in multiple sclerosis?

In this episode of the ECTRIMS Podcast, recorded in collaboration with the Multiple Sclerosis Journal "Controversies in MS" series, host Prof. Anneke van der Walt moderates a discussion between Prof. ...

3 Jun 33min

EBV and Multiple Sclerosis: Could Infection Hold the Key to MS?

Epstein–Barr virus (EBV) has become one of the most intensely studied topics in multiple sclerosis research. But how strong is the evidence linking EBV to MS, and could targeting the virus change the ...

15 Mai 29min

Fenebrutinib in Relapsing MS: FENhance Trial Results Explained

New Phase 3 data presented at the AAN conference 2026 provide compelling evidence that fenebrutinib may represent a high-efficacy oral treatment option for people living with relapsing multiple sclero...

22 Apr 26min